# MADCAM1

## Overview
MADCAM1 is a gene that encodes the mucosal vascular addressin cell adhesion molecule 1 (MAdCAM-1), a protein that plays a pivotal role in the immune system by mediating the trafficking of lymphocytes to mucosal tissues. MAdCAM-1 is a member of the immunoglobulin superfamily and is characterized by its immunoglobulin-like domains and a mucin-like region, which are essential for its function as a cell adhesion molecule. The protein is predominantly expressed on the endothelium of mucosal tissues, such as the high endothelial venules of Peyer's patches, and is crucial for directing lymphocytes to the gut mucosa through its interaction with integrin α4β7. This interaction is vital for immune surveillance and response, particularly in the context of inflammatory bowel diseases and other conditions involving mucosal immunity (Salmi2001Immune; Ogawa2005Mechanisms; Tan1998The).

## Structure
MADCAM1 (mucosal vascular addressin cell adhesion molecule 1) is a protein characterized by its immunoglobulin superfamily (IgSF) domains, which play a crucial role in its function. The protein consists of two amino-terminal Ig-like domains, followed by a mucin-like region. The first Ig domain contains a critical integrin-binding motif, with Asp42 located in the CD loop, essential for binding to α4 integrins (Green1999Mutational; Tan1998The). The second domain features a negatively charged DE β ribbon, which is important for binding to the integrin α4β7 (Green1999Mutational; Tan1998The).

The mucin-like domain is heavily O-glycosylated, extending the protein above the cell surface and facilitating its role in cell adhesion (Wang1998Structural). This domain also contributes to the protein's dual function as both an integrin and selectin ligand, mediating lymphocyte rolling and trafficking (Springer1994Traffic).

MADCAM1 can form dimers within the crystal lattice, although it predominantly exists in monomeric form in solution (Dando2002A). The protein's structure and post-translational modifications are crucial for its role in leukocyte trafficking and integrin recognition.

## Function
Mucosal addressin cell adhesion molecule 1 (MAdCAM-1) is a critical protein involved in the trafficking of lymphocytes to mucosal tissues, playing a significant role in immune surveillance and response. It is expressed on the endothelium of mucosal tissues, particularly in the high endothelial venules of Peyer's patches and other gut-associated lymphoid tissues (Salmi2001Immune; Tan1998The). MAdCAM-1 facilitates the adhesion and migration of lymphocytes by interacting with the integrin α4β7, which is crucial for directing lymphocytes to the gut mucosa (Ogawa2005Mechanisms; Tan1998The).

The protein has a dual function, binding integrin α4β7 for firm adhesion and L-selectin for transient adhesion, which aids in leukocyte rolling and firm adhesion on the endothelium (Tan1998The). This interaction is essential for regulating lymphocyte trafficking to both normal and inflamed mucosal tissues, maintaining immune homeostasis (Ogawa2005Mechanisms). MAdCAM-1's expression is inducible by inflammatory cytokines, highlighting its role in immune responses during inflammation (Ogawa2005Mechanisms). The structural features of MAdCAM-1, including its immunoglobulin superfamily domains, are important for its specific binding to integrins, which is vital for its function in immune cell trafficking (Tan1998The).

## Clinical Significance
MADCAM1 plays a significant role in the pathogenesis of inflammatory bowel diseases (IBD) such as ulcerative colitis (UC) and Crohn's disease. Alterations in MADCAM1 expression and its interactions are linked to these conditions. In UC, the disease activity is influenced by the posttranslational modification of MADCAM1 with L-selectin ligand carbohydrates, rather than its expression levels alone. This modification, mediated by GlcNAc6ST-1, is crucial during the active phase of UC, suggesting that targeting these modifications could be a therapeutic strategy (Kobayashi2009GlcNAc6ST1mediated).

In the context of primary sclerosing cholangitis (PSC) and IBD, increased MADCAM1 expression is associated with active disease states, facilitating lymphocyte trafficking along the gut-liver axis. This suggests that MADCAM1 expression changes could have clinical significance in diseases involving the gut-liver axis (Gao2021Bile).

Therapeutic interventions targeting MADCAM1 interactions, such as the use of vedolizumab, aim to inhibit lymphocyte adhesion to MADCAM1, thereby reducing inflammatory infiltration in the gut. These therapies highlight the clinical importance of MADCAM1 in managing IBD (Binder2018Similar).

## Interactions
MADCAM1, or mucosal vascular addressin cell adhesion molecule 1, is primarily involved in interactions with integrins, particularly integrin α4β7. This interaction is crucial for the homing of lymphocytes to mucosal tissues. MADCAM1 contains immunoglobulin superfamily domains that facilitate its binding to integrins. The first domain includes a key integrin-binding residue, Asp42, while the second domain features a negatively charged DE β ribbon, which is important for orienting the integrin-binding face of MADCAM1 and enhancing its interaction with α4β7 integrin (Tan1998The).

Mutational analyses have identified specific residues in MADCAM1 that are critical for its binding to integrin α4β7. These include residues in the interstrand loops of the first and second immunoglobulin domains, such as R39, L41, D42, and E148, among others. Alterations in these residues can significantly affect binding affinity (Green1999Mutational).

The interaction between MADCAM1 and integrin α4β7 is also influenced by the presence of divalent metal ions like Ca2+ and Mg2+, which are essential for integrin activation and binding. These ions facilitate a catch-bond-slip-bond conversion mechanism, enhancing the adhesion of lymphocytes under physiological conditions (Su2023The).


## References


[1. (Salmi2001Immune) Marko Salmi, Kalle Alanen, Seija Grenman, Michael Briskin, Eugene C. Butcher, and Sirpa Jalkanen. Immune cell trafficking in uterus and early life is dominated by the mucosal addressin madcam-1 in humans. Gastroenterology, 121(4):853–864, October 2001. URL: http://dx.doi.org/10.1053/gast.2001.27968, doi:10.1053/gast.2001.27968. This article has 41 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1053/gast.2001.27968)

[2. (Green1999Mutational) Nancy Green, Josh Rosebrook, Nancy Cochran, Kemin Tan, Jia-Huai Wang, Timothy A. Springer, and Michael J. Briskin. Mutational analysis of madcam-1/α4β7 interactions reveals significant binding determinants in both the first and second immunoglobulin domains. Cell Adhesion and Communication, 7(3):167–181, January 1999. URL: http://dx.doi.org/10.3109/15419069909010800, doi:10.3109/15419069909010800. This article has 16 citations.](https://doi.org/10.3109/15419069909010800)

[3. (Wang1998Structural) Jia‐huai Wang and Timothy A. Springer. Structural specializations of immunoglobulin superfamily members for adhesion to integrins and viruses. Immunological Reviews, 163(1):197–215, June 1998. URL: http://dx.doi.org/10.1111/j.1600-065x.1998.tb01198.x, doi:10.1111/j.1600-065x.1998.tb01198.x. This article has 136 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1111/j.1600-065x.1998.tb01198.x)

[4. (Kobayashi2009GlcNAc6ST1mediated) Motohiro Kobayashi, Hitomi Hoshino, Junya Masumoto, Mana Fukushima, Kenichi Suzawa, Shunsuke Kageyama, Manabu Suzuki, Haruo Ohtani, Minoru Fukuda, and Jun Nakayama. Glcnac6st-1-mediated decoration of madcam-1 protein with l-selectin ligand carbohydrates directs disease activity of ulcerative colitis. Inflammatory Bowel Diseases, 15(5):697–706, May 2009. URL: http://dx.doi.org/10.1002/ibd.20827, doi:10.1002/ibd.20827. This article has 46 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/ibd.20827)

[5. (Gao2021Bile) Rachel Y. Gao, Colin T. Shearn, David J. Orlicky, Kayla D. Battista, Erica E. Alexeev, Ian M. Cartwright, Jordi M. Lanis, Rachael E. Kostelecky, Cynthia Ju, Sean P. Colgan, and Blair P. Fennimore. Bile acids modulate colonic madcam-1 expression in a murine model of combined cholestasis and colitis. Mucosal Immunology, 14(2):479–490, March 2021. URL: http://dx.doi.org/10.1038/s41385-020-00347-6, doi:10.1038/s41385-020-00347-6. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41385-020-00347-6)

[6. (Su2023The) Youmin Su, Zhiqing Luo, Dongshan Sun, Bishan Yang, and Quhuan Li. The force-dependent mechanism of an integrin α4β7–madcam-1 interaction. International Journal of Molecular Sciences, 24(22):16062, November 2023. URL: http://dx.doi.org/10.3390/ijms242216062, doi:10.3390/ijms242216062. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms242216062)

[7. (Springer1994Traffic) Timothy A. Springer. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell, 76(2):301–314, January 1994. URL: http://dx.doi.org/10.1016/0092-8674(94)90337-9, doi:10.1016/0092-8674(94)90337-9. This article has 5339 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/0092-8674(94)90337-9)

[8. (Binder2018Similar) Marie-Theres Binder, Emily Becker, Maximilian Wiendl, Lena Schleier, Friederike Fuchs, Moritz Leppkes, Raja Atreya, Clemens Neufert, Imke Atreya, Markus F Neurath, and Sebastian Zundler. Similar inhibition of dynamic adhesion of lymphocytes from ibd patients to madcam-1 by vedolizumab and etrolizumab-s. Inflammatory Bowel Diseases, 24(6):1237–1250, May 2018. URL: http://dx.doi.org/10.1093/ibd/izy077, doi:10.1093/ibd/izy077. This article has 32 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/ibd/izy077)

[9. (Dando2002A) J. Dando, K. W. Wilkinson, S. Ortlepp, D. J. King, and R. L. Brady. A reassessment of the madcam-1 structure and its role in integrin recognition. Acta Crystallographica Section D Biological Crystallography, 58(2):233–241, January 2002. URL: http://dx.doi.org/10.1107/s0907444901020522, doi:10.1107/s0907444901020522. This article has 17 citations.](https://doi.org/10.1107/s0907444901020522)

[10. (Tan1998The) Kemin Tan, Jose M Casasnovas, Jin-huan Liu, Michael J Briskin, Timothy A Springer, and Jia-huai Wang. The structure of immunoglobulin superfamily domains 1 and 2 of madcam-1 reveals novel features important for integrin recognition. Structure, 6(6):793–801, June 1998. URL: http://dx.doi.org/10.1016/s0969-2126(98)00080-x, doi:10.1016/s0969-2126(98)00080-x. This article has 51 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/s0969-2126(98)00080-x)

[11. (Ogawa2005Mechanisms) Hitoshi Ogawa, David G. Binion, Jan Heidemann, Monica Theriot, Pamela J. Fisher, Nathan A. Johnson, Mary F. Otterson, and Parvaneh Rafiee. Mechanisms of madcam-1 gene expression in human intestinal microvascular endothelial cells. American Journal of Physiology-Cell Physiology, 288(2):C272–C281, February 2005. URL: http://dx.doi.org/10.1152/ajpcell.00406.2003, doi:10.1152/ajpcell.00406.2003. This article has 54 citations.](https://doi.org/10.1152/ajpcell.00406.2003)